Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms

Vaccine

Volumn 27, Issue 6, 2009, Pages 919-927

  Loeffler, Daniela I M ^a   Smolen, Kinga ^a   Aplin, Laura ^a   Cai, Bing ^a   Kollmann, Tobias R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Listeria monocytogenes; Live vaccines; Newborns

Indexed keywords

BACTERIAL VACCINE; IMMUNOGLOBULIN G ANTIBODY; LISTERIA MONOCYTOGENES VACCINE; LIVE VACCINE; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROL GROUP; CONTROLLED STUDY; CYTOSOL; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MOUSE; NEWBORN; NONHUMAN; PHAGOSOME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECOMBINANT PLASMID; VACCINATION; WILD TYPE;

ANIMALS; ANTIBODIES; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLONY COUNT, MICROBIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LIVER; LUNG; MICE; OVALBUMIN; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 58249113116     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.047     Document Type: Article

References (46)

1. Adkins B., Leclerc C., and Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 4 July (7) (2004) 553-564
2. Siegrist C.A. The challenges of vaccine responses in early life: selected examples. J Comp Pathol 137 July (Suppl. 1) (2007) S4-9
3. Siegrist C.-A. Vaccination in the neonatal period and early infancy. Int Rev Immunol 19 2 (2000) 195-219
4. Siegrist C.-A. Neonatal and early life vaccinology. Vaccine 19 25-26 (2001) 3331-3346
5. Wilson C.B., and Kollmann T.R. Induction of antigen-specific immunity in human neonates and infants. Nestle Nutr Workshop Ser Pediatr Program 61 (2008) 183-195
6. Wilson C.B., Lewis D.B., and English B.K. T cell development in the fetus and neonate. Adv Exp Med Biol 310 (1991) 17-27
7. Marchant A., and Goldman M. T cell-mediated immune responses in human newborns: ready to learn?. Clin Exp Immunol 141 July (1) (2005) 10-18
8. Marchant A., Appay V., Van Der Sande M., Dulphy N., Liesnard C., Kidd M., et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 111 June (11) (2003) 1747-1755
9. Fadel S.A., Ozaki D.A., and Sarzotti M. Enhanced type 1 immunity after secondary viral challenge in mice primed as neonates. J Immunol 169 September (6) (2002) 3293-3300
10. Kollmann T.R., Reikie B., Blimkie D., Way S.S., Hajjar A.M., Arispe K., et al. Induction of protective immunity to Listeria monocytogenes in neonates. J Immunol 178 March (6) (2007) 3695-3701
11. Kotton C.N., and Hohmann E.L. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect Immun 72 October (10) (2004) 5535-5547
12. Fouts T.R., DeVico A.L., Onyabe D.Y., Shata M.T., Bagley K.C., Lewis G.K., et al. Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1. FEMS Immunol Med Microbiol 37 July (2-3) (2003) 129-134
13. Bruhn K.W., Craft N., and Miller J.F. Listeria as a vaccine vector. Microbes Infect 9 August (10) (2007) 1226-1235
14. Brockstedt D.G., and Dubensky T.W. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies. Exp Rev Vaccines 7 7 (2008) 1069-1084
15. Stevens R., Lavoy A., Nordone S., Burkhard M., and Dean G.A. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine. Vaccine 23 February (12) (2005) 1479-1490
16. Soussi N., Milon G., Colle J.H., Mougneau E., Glaichenhaus N., and Goossens P.L. Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major. Infect Immun 68 March (3) (2000) 1498-1506
17. Lieberman J., and Frankel F.R. Engineered Listeria monocytogenes as an AIDS vaccine. Vaccine 20 15 (2002) 2007-2010
18. Angelakopoulos H., Loock K., Sisul D.M., Jensen E.R., Miller J.F., and Hohmann E.L. Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect Immun 70 July (7) (2002) 3592-3601
19. Vazquez-Boland J.A., Kuhn M., Berche P., Chakraborty T., Dominguez-Bernal G., Goebel W., et al. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14 July (3) (2001) 584-640
20. Pamer E.G. Immune responses to Listeria monocytogenes. Nat Rev Immunol 4 October (10) (2004) 812-823
21. Bauer H., Darji A., Chakraborty T., and Weiss S. Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids. Gene Ther 12 February (4) (2005) 364-372
22. Spreng S., and Viret J.-F. Plasmid maintenance systems suitable for GMO-based bacterial vaccines. Vaccine 23 17-18 (2005) 2060-2065
23. Loeffler D.I., Schoen C.U., Goebel W., and Pilgrim S. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes. Infect Immun 74 July (7) (2006) 3946-3957
24. Khanolkar A., Badovinac V., and Harty J. CD8 T cell memory development: CD4 T cell help is appreciated. Immunol Res 39 1 (2007) 94-104
25. Park S.F., and Stewart G.S. High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells. Gene 94 September (1) (1990) 129-132
26. Ermolaeva S., Novella S., Vega Y., Ripio M.-T., Scortti M., and Vazquez-Boland J.A. Negative control of Listeria monocytogenes virulence genes by a diffusible autorepressor. Mol Microbiol 52 2 (2004) 601-611
27. Laemmli U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 227 5259 (1970) 680-685
28. Moors M.A., Levitt B., Youngman P., and Portnoy D.A. Expression of listeriolysin O and ActA by intracellular and extracellular Listeria monocytogenes. Infect Immun 67 January (1) (1999) 131-139
29. Bubert A., Sokolovic Z., Chun S.K., Papatheodorou L., Simm A., and Goebel W. Differential expression of Listeria monocytogenes virulence genes in mammalian host cells. Mol Gen Genet 261 March (2) (1999) 323-336
30. Pilgrim S., Stritzker J., Schoen C., Kolb-Maurer A., Geginat G., Loessner M.J., et al. Bactofection of mammalian cells by Listeria monocytogenes: improvement and mechanism of DNA delivery. Gene Ther 10 November (24) (2003) 2036-2045
31. Galen J.E., and Levine M.M. Can a 'flawless' live vector vaccine strain be engineered?. Trends Microbiol 9 8 (2001) 372-376
32. + T cells after infection. Nat Immunol 3 July (7) (2002) 619-626
33. Montoya M., and Del Val M. Intracellular rate-limiting steps in MHC class I antigen processing. J Immunol 163 August (4) (1999) 1914-1922
34. + T lymphocytes. Nature 421 February (6925) (2003) 852-856
35. Herskovits A.A., Auerbuch V., and Portnoy D.A. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 3 March (3) (2007) e51
36. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., and Portnoy D.A. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 4 January (1) (2008) e6
37. McCaffrey R.L., Fawcett P., O'Riordan M., Lee K.D., Havell E.A., Brown P.O., et al. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc Natl Acad Sci USA 101 August (31) (2004) 11386-11391
38. Bahjat K.S., Liu W., Lemmens E.E., Schoenberger S.P., Portnoy D.A., Dubensky Jr. T.W., et al. Cytosolic entry controls CD8+-T-cell potency during bacterial infection. Infect Immun 74 November (11) (2006) 6387-6397
39. Brzoza K.L., Rockel A.B., and Hiltbold E.M. Cytoplasmic entry of Listeria monocytogenes enhances dendritic cell maturation and T cell differentiation and function. J Immunol 173 August (4) (2004) 2641-2651
40. Busch D.H., and Pamer E.G. MHC Class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J Immunol 160 May (9) (1998) 4441-4448
41. Badovinac V.P., and Harty J.T. Intracellular staining for TNF and IFN-gamma detects different frequencies of antigen-specific CD8(+) T cells. J Immunol Methods 238 April (1-2) (2000) 107-117
42. Skoberne M., and Geginat G. Efficient in vivo presentation of Listeria monocytogenes- derived CD4 and CD8 T cell epitopes in the absence of IFN-gamma. J Immunol 168 February (4) (2002) 1854-1860
43. Byun H.J., Jung W.W., Lee J.B., Chung H.Y., Sul D., Kim S.J., et al. An evaluation of the neonatal immune system using a listeria infection model. Neonatology 92 2 (2007) 83-90
44. Adkins B. Neonatal T cell function. J Pediatr Gastroenterol Nutr 40 Suppl. 1 (2005) 5-7
45. Snapper C.M., and Paul W.E. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236 May (4804) (1987) 944-947
46. Schoen C., Loeffler D.I.M., Frentzen A., Pilgrim S., Goebel W., and Stritzker J. Listeria monocytogenes as novel carrier system for the development of live vaccines. Int J Med Microbiol 298 1-2 (2008) 45-58